Merus N.V. (MRUS) is a Dutch developer of antibody therapeutics targeting cancer. These antibodies are bispecific and trispecific IgG antibodies developed using Merus' Multiclonics platform. Lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results